Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

Research Institute of the McGill University Health Centre

$416,924.00

Tuberculosis in Canada: Modeling to Inform Elimination

FY 2019-20

Summary
Tuberculosis (TB) causes more deaths worldwide than any other infectious agent: 1.5 million deaths in 2018. The World Health Organization has set key targets for TB reduction and elimination. For countries like Canada, with higher income and lower TB incidence, the targets are to reduce incidence to 1 case per 100,000 population by 2035, and to 1 per million by 2050. However, Canadian TB rates have not changed for over a decade, and have reached a plateau just under 5 cases per 100,000. Over 70% of these cases occur in foreign-born persons. Progress toward elimination will not be possible without better approaches to prevention in this group. This proposal uses computer simulation of tuberculosis epidemiology and trends to examine the potential impact and cost of potential new approaches, over the period between 2020 and 2050. Specifically, we will: 1.Predict the long-term epidemiologic and economic impact of broadened pre- and post-migration screening for dormant TB infection among migrants to Canada. 2.Predict the impact of shorter, more effective, and safer treatment regimens for dormant TB infection, as well as the impact of new technologies, such as better tests for dormant infection, and a new TB vaccine, among migrants. 3.Consider the impact of investment in specific elements of TB prevention and care in high-incidence countries, with respect to their downstream implications for Canada and other countries which receive large numbers of migrants. 4. Consider the ethical implications of these new approaches, including potential stigmatization and treatment risks. This work will provide relevant information to decision makers, including public health and immigration medical authorities. It will also pave the way for better information sharing and input from affected communities. Findings will also be highly relevant to other low-incidence, higher-income, migrant receiving countries.
Program
Project Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
420023
Name
Schwartzman Kevin
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Public, Community & Population Health 2
Projecttitle
Tuberculosis in Canada: Modeling to Inform Elimination
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$416,924
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cost-Effectiveness; Decision Analysis; Ethics; Migrants; Prediction; Public Health; Screening; Tuberculosis
Abstract
Tuberculosis (TB) causes more deaths worldwide than any other infectious agent: 1.5 million deaths in 2018. The World Health Organization has set key targets for TB reduction and elimination. For countries like Canada, with higher income and lower TB incidence, the targets are to reduce incidence to 1 case per 100,000 population by 2035, and to 1 per million by 2050. However, Canadian TB rates have not changed for over a decade, and have reached a plateau just under 5 cases per 100,000. Over 70% of these cases occur in foreign-born persons. Progress toward elimination will not be possible without better approaches to prevention in this group. This proposal uses computer simulation of tuberculosis epidemiology and trends to examine the potential impact and cost of potential new approaches, over the period between 2020 and 2050. Specifically, we will: 1.Predict the long-term epidemiologic and economic impact of broadened pre- and post-migration screening for dormant TB infection among migrants to Canada. 2.Predict the impact of shorter, more effective, and safer treatment regimens for dormant TB infection, as well as the impact of new technologies, such as better tests for dormant infection, and a new TB vaccine, among migrants. 3.Consider the impact of investment in specific elements of TB prevention and care in high-incidence countries, with respect to their downstream implications for Canada and other countries which receive large numbers of migrants. 4. Consider the ethical implications of these new approaches, including potential stigmatization and treatment risks. This work will provide relevant information to decision makers, including public health and immigration medical authorities. It will also pave the way for better information sharing and input from affected communities. Findings will also be highly relevant to other low-incidence, higher-income, migrant receiving countries.
Competitiondate
202003
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Schwartzman, Kevin; Johnston, James C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $416,924~ $0~
Research Institute of the McGill University Health Ce… | Canada Spends